Investor Relations

Company Overview

Calyxt (Nasdaq: CLXT) is a plant-based synthetic biotechnology company. The Company leverages its proprietary PlantSpring™ technology platform to engineer innovative materials and products for its customers to help them meet their sustainability goals. Calyxt’s diversified offerings are delivered through its proprietary BioFactory™ manufacturing process.

Latest Financial Results

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2020

Investor Contact Information

Company

Calyxt, Inc.
2800 Mount Ridge Road
Roseville, MN 55113

Investor Relations

Argot Partners
Sherri Spear
T: 212-600-1902
investors@calyxt.com

Transfer Agent

Broadridge Corporate Issuer Solutions, Inc.
1155 Long Island Avenue
Edgewood, NY 11717
T: 1-877-830-4932
www.broadridge-ir.com/resources/transfer-agent/default.aspx

Market Data copyright © 2021 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.